Immediate Impact
64 standout
Citing Papers
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2025 Standout
The therapeutic potential of circular RNAs
2025 Standout
Works of Pengsheng Yi being referenced
Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
2023
The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Pengsheng Yi | 100 | 81 | 37 | 313 | 309 | 25 | 458 | |
| Xiaogeng Deng | 78 | 70 | 14 | 280 | 237 | 20 | 426 | |
| Tiefeng Cao | 31 | 45 | 15 | 255 | 172 | 24 | 541 | |
| Guohong Ge | 142 | 46 | 10 | 283 | 308 | 17 | 521 | |
| Junhao Zheng | 112 | 83 | 30 | 283 | 218 | 29 | 465 | |
| Irene Isabel P. Lim | 156 | 160 | 34 | 231 | 147 | 30 | 544 | |
| Gyeonghwa Kim | 44 | 18 | 11 | 342 | 323 | 20 | 448 | |
| Suofeng Sun | 87 | 28 | 18 | 311 | 245 | 24 | 525 | |
| Mio Endo | 60 | 45 | 55 | 306 | 128 | 21 | 512 | |
| Chunlin Jiang | 217 | 88 | 51 | 193 | 189 | 23 | 515 | |
| R. Buurman | 24 | 75 | 47 | 331 | 240 | 23 | 469 |
All Works
Loading papers...